Vice President @ PhysioSign USA | Non-invasive EP system with advanced ECG monitorđ«| Built on 15m recordings | 53 US & International patents | CE MDR Certified
P-Delta Interval
While the traditional ECG findings in **WPW syndrome** are well understood, the key limitation is what it cannot show. Traditional ECGs can display the Delta wave without difficulty, but they cannot resolve the complex, convoluted signals hidden within it. The Delta wave simply appears as a slurred, widened upstroke.
In contrast, new ECG can reveal the Purkinje fiber activity and other fine signals concealed inside the Delta wave. This is the crucial advantage. While everyone can see the Delta wave on a standard ECG, traditional systems cannot display what is hidden within it â sometimes bundle branch potentials, and sometimes both His bundle and bundle branch potentials. This capability serves as strong proof that the new ECG can successfully record His bundle and bundle branch potentials.
Using WPW syndrome as a disease model, we can clearly demonstrate what the new ECG is capable of capturing. The disease itself validates the authenticity, reliability, clinical utility, and practical applicability of the new ECGâs images and data.
đ«Key Clinical Advantages
Measurement of P-Delta Interval
Traditional ECGs cannot measure the P-to-Delta interval. The new ECG can measure it accurately. This is particularly important because the interval is essential for ablation planning. By subtracting the atrial conduction time from the P-Delta interval, we can derive the hidden conduction time â providing the critical distance needed for surgical or ablation procedures.
đ«Localization of the Conduction System
The new ECG can localize the His-Purkinje system, which is difficult or impossible with traditional surface ECG.
đ«Unique Disease-Specific Parameter
The P-Delta interval does not exist in healthy individuals â it only appears in WPW syndrome. This makes WPW a unique clinical model that neither traditional ECG nor even conventional invasive EP studies can fully characterize.
âïžPre- and Post-Surgery Validation
WPW syndrome provides compelling clinical evidence supporting the new ECG. In WPW, the HV interval appears to disappear. The question is: where is it displaced and hidden? Is it partially or completely shifted? Since the AV node (AVN) cannot be displaced due to its fixed anatomical position, this becomes a key question.
The new ECG can reveal the hidden and displaced HV interval signals within the Delta wave. This proves it has successfully captured the full electrical potentials of the entire cardiac conduction system (SCS).
Conversely, after successful RFA surgery:
Before RFA: HV interval image disappears with blank data.
After RFA: HV interval image reappears, data returns to normal, and the Delta wave disappears.
Using pre- and post-operative images and data for direct comparison is one of the simplest and most convincing ways to validate the new ECG.
PhysioSign
#ECG
#Cardiology
#WPW
New Generation of Vital Sign Monitoring
Patent number: 12239448
Why Are Monitors Susceptible to Interference Drift?
Monitors are designed for continuous 24-hour operation. However, the polarization voltage on the human bodyâs surface is highly prone to interference. In enclosed environments over extended periods, this voltage becomes unstable, making signal drift inevitable and unavoidable.
At PhysioSign, we have developed a patented technology for processing electrical signals that completely eliminates driftâregardless of its intensity, even when it exceeds the baseline. This breakthrough is unique worldwide and the only solution of its kind.
This patented innovation revolutionizes traditional monitors by enabling true 24-hour dynamic ECG monitoring. It represents a groundbreaking advancement in electrocardiographyâ120 years after its inventionâfully resolving one of the most persistent and difficult challenges in the field.
The conventional trio of parameters (ECG, NIBP, and SpOâ) often falls short in critical care. Their delayed response to changes in vital signs can hinder timely intervention.
The new generation of monitors changes this paradigm. They can detect diseases before they fully manifest, at their earliest onset, or during intermittent episodes. These systems deliver automatic, intelligent warningsâwithout requiring constant manual oversight by doctors and nurses, especially during nighttime hours.
Notably, the new monitors excel at identifying high-risk conditions such as:
Myocardial infarction without typical ECG changes Acute coronary syndrome (ACS)
Atrial fibrillation combined with myocardial infarction Conduction block with myocardial infarction
They provide continuous, vigilant protection, enabling proactive care before emergencies arise. In addition, the integration of non-invasive cardiac function and cardiac output monitoring (without intubation) dramatically expands clinical utility.
Since the invention of vital sign monitors in 1957, this marks the first major reinvention in the field. Powered by a groundbreaking âimage/data/AIâ automation framework, these monitors are entering a new eraâdelivering higher accuracy, intelligence, and clinical value than ever before.
Most importantly:
New vital sign monitoring can now provide early warnings for potential sudden cardiac events up to 2 weeks in advance.
â ECG, SpOâ, NIBP, RR, HR, Temperature
â New Electrophysiological Imaging
â Early Detection of: Heart Failure and/or Acute
â Myocardial Infarction (AMI)
â Acute Coronary Syndrome (ACS)
â Infarct-avid myocardial imaging
â Complete Right Bundle Branch Block (CRBBB) with AMI
â Complete Left Bundle Branch Block (CLBBB) with AMI
â Atrial Fibrillation (A-fib) with AMI
â Latent lesions prior to sudden cardiac death
â Wellens Syndrome
â de Winter Syndrome
â Sgarbossa Syndrome
đĄAdvanced Insights:
â Non-invasive cardiac output (CO) monitoring based on Frank-Starling Law curve
â Invasive electrophysiology data: PA, AH, and HV intervals
â Detection of AMI and OMI even when standard ECG appears normal
PhysioSign
#signalprocessing
#vitalsignmonitoring
How can we effectively identify patients who need a pacemaker in large, busy populations â before a sudden cardiac event occurs?
Currently, only 0.3%â0.5% of patients have a pacemaker implanted. This remains one of the biggest challenges in cardiac care today. Standard ECG screening frequently misses âhiddenâ high-risk patients who truly require pacemaker implantation.
Pacemaker patients can mainly be divided into the following four categories:
Heart Failure Patients
This is by far the largest group! Traditional ECG has a very low detection rate (almost close to 0) for conduction abnormalities in heart failure patients. Many patients who are suitable for Cardiac Resynchronization Therapy (CRT) pacemakers are missed. saahECG, with its advanced AI technology, can more accurately detect issues such as ventricular dyssynchrony, greatly increasing diagnosis and treatment opportunities for these patients.
Atrial Fibrillation Patients
Especially those with severe atrial fibrillation, scarred atrial fibrillation, long-standing persistent atrial fibrillation, and patients with comorbidities such as hypertension and diabetes. In the later stages, medication often becomes ineffective for these patients, and they may develop rapid atrial fibrillation combined with malignant ventricular tachycardia. At this point, pacemaker implantation is often necessary to control heart rate or for further treatment.
Patients after Electrophysiological Procedures
Approximately 50% of patients who have undergone radiofrequency ablation surgery will later require a pacemaker. This is because the ablation process may damage the endocardium or the conduction system (especially near the atrioventricular node or His bundle), leading to conduction block that requires a pacemaker to maintain normal heart rhythm.
Elderly Patients
Patients over 80 years old. Due to degeneration of the sinus node function or the conduction system, many develop sick sinus syndrome or high-degree atrioventricular block. These patients represent a classic group for pacemaker implantation.
saahECG technology:
âąÂ Heart failure image scan detection rate: 75% (vs 0% with conventional ECG)
âą Atrial fibrillation imaging scan detection rate: 99.99% (even without F-wave)
âą ACS (Acute Coronary Syndrome): 93% (vs almost 0% with conventional ECG)
âą Non-episodic malignant tachycardia (AVNRT/AVRT): 75% (vs 0% with conventional ECG)
These two conditions (HF & A-fib) alone represent a massive population that may need pacing support. Many of these patients are reluctant to undergo invasive EP studies until an acute event forces the issue. As a result, countless high-risk individuals miss the optimal window for life-saving intervention.
saahECG offers a new non-invasive approach to large-scale screening that can detect concealed conduction system abnormalities â including SAN micro-potentials and precise HV intervals â which are extremely difficult to capture with conventional methods.
By revealing these hidden risks earlier and more accurately, this technology has the potential to help physicians identify the right patients for timely pacemaker therapy â ultimately saving lives.
PhysioSign
#ECG
#pacemaker
#Cardiology
Atrial Fibrillation
The heart is an âelastic mucous organâ that carries micro-electric potentials. Undoubtedly, the ECG is the most direct electrophysiological recording of human life. Invasive electrophysiological test directly probe the Bundle of His, while traditional ECGs only record the life trajectories of the atria (P-wave) and ventricles (T-wave). What is missing between them is the local potentials and membrane potentials of the cardiac self-conduction-system.
The new ECG (saahECG) fills this gap. For example, within a single P-wave (typically 120â210 ms), the new ECG can clearly display the sequence:
Atrial-wave â AVN-wave â His bundle-wave â Bundle branch-waves â Purkinje fiber waves. (Please refer to the attached figure.)
đ«Atrial Fibrillation (A-fib)
In cases of Atrial Fibrillation often without obvious F-waves, traditional ECGs often struggle to make a clear diagnosis. This is especially true for paroxysmal AF or non-sustained AF, where there is no fixed focal source. The chaotic wavelets appear and disappear constantly. The longer the disease duration, the more severe the atrial fibrosis and the greater the number of fibrillation sources. As a result, many AF patients do not exhibit visible F-waves on standard ECGs.
đ«The new ECG does not rely on F-waves. It only needs take to look at the AVN wave in each heartbeat. When the electrical potential traveling from the atrium to the AVN fails to reach the conduction threshold, the AVN wave amplitude decreases significantly and falls below the His bundle amplitude â this indicates Atrial Fibrillation. This detection works even in silent, concealed, paroxysmal, or non-sustained AF, including AF originating from the pulmonary veins, left atrial posterior wall, septum, left atrial appendage, right atrium, or widespread substrate areas.
đThe most critical advantage is that even during periods when Atrial Fibrillation is not actively fibrillating (i.e., normal sinus rhythm on surface ECG), the new ECG can still detect the presence of AF, while traditional ECGs show no abnormality. For patients with long-term and severe Atrial Fibrillation, most of them have no F-wave, and they often suffer from severe arrhythmias or ventricular arrhythmias. As a result, they lose the opportunity to have a pacemaker implanted.
đĄTotal sample size: Over 15 million
đ«AF Image display rate: 99.99%
đ„AF AI detection rate: 97%
â Occult AF rate: 93% (From 0% to 93%)
â AF (without F-wave): 93% (From 0% to 93%)
đ„AF correlation rate: 99%
đĄFalse positive rate: 3%
đĄFalse negative rate: 0.5%
PhysioSign
CE MDR Certified
#ecg
#electrophysiology
ionic signal (saahECG) vs cellular signal (standard ECG)
It is perhaps easiest to explain this using WPW images.
The electrophysiological principle of WPW is that ventricular depolarization is pre-excited via an accessory pathway and occurs at the end of the AV node (AVN). The position of the His bundle and the bundle branches is anatomically fixed. Therefore, the diagnostic criteria of traditional ECGs originate from anatomical electrophysiology. The classic image shows a shortened P-R interval (<120 ms, which is abnormal â note that the normal SANâAVN conduction time upper limit is 120 ms) and a widened QRS duration (>120 ms, also abnormal).Â
Why is this maximum value considered normal in the diagnostic framework? It is because the normal HV interval ranges from 30 to 55 ms on average. Ventricular pre-excitation ends in the AH interval before the HV interval begins, since the atrial conduction time [PA interval + AH interval] is <120 ms. This is one of the key rules for assessing pre-excitation: the ventricles are activated before atrial conduction is complete. However, atrial conduction continues through the HV interval, causing the QRS complex to widen due to fusion with the pre-excited ventricular activation. As a result, the normal average QRS duration (<80 ms) becomes prolonged (>120 ms).Â
These are all remarkable historical conjectures that are consistent with physiology, pathology, electrophysiology, and anatomy. The new ECG (saahECG) records ion-level signals. It can sample and display microvolt (ÎŒV) ion signals within the widened QRS complex, thereby revealing the His bundle notch and the extremely small waves from the left and right bundle branches.Â
In contrast, conventional ECGs only record millivolt (mV) cell-level signals. Consequently, the fine electrical activity within the widened QRS is not visible. For the first time, the high-sensitivity imaging of the new ECG has confirmed the historical delta wave conjecture of WPW and will also help validate or correct some previously inaccurate assumptions. Since the left and right bundle branches divide into two separate pathways, stronger electrical potential is required for conduction. In cases of abnormality, the activation position may shift over time, causing signals to appear after QRS pre-excitation â further confirming the WPW mechanism.
The His bundle connects to the AVN at its anterior end and to the left and right bundle branches at its posterior end. This middle segment conducts unidirectionally and normally produces no visible signal. Therefore, when it is superimposed within the QRS pulse wave, only a notch is displayed.
***Core Knowledge The physical scale, energy, and conduction units of ionic signals are far smaller than those of cellular signals. The physical principles of the new small waves***
Honoring the Giants Who Shaped Modern Cardiac Electrophysiology
Today, I want to pay tribute to two extraordinary pioneers whose groundbreaking work laid the foundation for our understanding of the heartâs electrical system:
Dr. Brian F. Hoffman â A true legend in basic cardiac electrophysiology. Through his pioneering experiments on canine hearts, Dr. Hoffman mapped the anatomical origins of the EKGâs P-R interval and advanced our knowledge of specialized conduction tissues. He is widely regarded as one of the greatest electrophysiological scientists of our time and a key pioneer in invasive heart technologies.
Dr. Anthony N. Damato â Who took foundational basic science and translated it into clinical practice.
Dr. Damato made critical contributions by refining our understanding of the PR interval and developing techniques that enabled the recording of His bundle electrograms in humans â a milestone that essentially launched the field of clinical cardiac electrophysiology.
If the third industrial revolution had happened in the 1960s, Dr. Brian F. Hoffman would most likely have been the inventor of the new ECG.
Their combined legacy continues to influence every ECG we read today. We stand on the shoulders of these remarkable scientists. Their work reminds us that true innovation is built on deep scientific understanding and continuous advancement. Progress in cardiology is only possible because of the visionaries who came before us.
#Cardiology #Electrophysiology #ECG
Top row (Conventional ECG):
The P wave has a rounded, arc-shaped onset and offset.
The transition from the end of the P wave to the beginning of the QRS complex forms a curved (arc) angle rather than a sharp angle.
This makes it difficult to accurately locate the starting point of the PR interval, resulting in measurements that are highly subjective and less precise.
Bottom row (saahECG):
The P wave ends with a clear, sharp acute angle.
The junction between the P wave and the PR segment is well-defined and distinct.
This allows for precise and reproducible measurement of the PR interval.
PhysioSign
Clinical Value of a New Detection Method for Atrial Fibrillation (AF)
AF is one of the most common cardiac diseases, affecting approximately 25% of people over the age of 65. It is also a leading cause of stroke. In 2015, the United States alone reported approximately 1.5 million undiagnosed AF cases, accounting for roughly 11% of all AF patients. These individuals were unable to receive timely treatment. Globally, an estimated 35 million people with covert (silent) AF remain undiagnosed. AF significantly increases the risk of stroke, which is life-threatening. Heart attack and stroke are the leading causes of death worldwide.
History of Diagnostic Tools
The electrocardiogram (ECG), which has remained fundamentally unchanged since 1903, is still the only widely used diagnostic tool for AF. No other device has been able to reliably detect it. However, AF originates as fibrillation in the atria, while the ECGâs P-wave represents the entire atrial electrical activity (including the atrium, atrioventricular node, His bundle, and bundle branches). Traditional ECGs cannot independently display detailed atrial activity, resulting in low detection rates. A new ECG technology introduced in 2016 can detect F-waves in AF, including very rapid AF, very slow AF, and pre-symptomatic (silent) AF that traditional ECGs often miss. This is possible because the new system records different and more specific cardiac biomarkers.
Two Key Reasons for Superior Performance:
1. Dual ECG Scanning â PhysioSign simultaneously uses both traditional and new ECG technologies.
2. Advanced Imaging â The new ECG can visualize the sinoatrial node (SN), atrium, atrioventricular node (AVN), and His bundle. This enables not only precise diagnosis but also accurate localization of the problem.
***The underlying principle is straightforward: during AF, chaotic atrial activity prevents normal electrical signals from reaching the AVN. The saahECG clearly detects and displays the AVN images, which are divided into three distinct parts: AN, N, and NH***
PhysioSignâs non-invasive detection of the PA interval is a historic first. Previously, the PA interval could only be measured through invasive electrophysiological studies, which were unable to detect AF. The PA interval represents the time from the sinoatrial nodeâs pacing signal to its conduction through the atrium â an interval not visible on ECGs.
đĄ Total sample size: Over 15 million
đ« Image display rate: 99.99%
đ„ AI detection rate: 97%
â Occult AF rate: 93% (From 0% to 93%)
â AF (without F-wave): 93% (From 0% to 93%)
đ„ AF correlation rate: 99%
đĄ False positive rate: 3%
đĄ False negative rate: 0.5%
PhysioSign
**CE MDR Certified
#ECG
#AI
The worldâs only U.S.-patented ECG electrode
Some people may assume that all ECG machines on the market are similar in quality and disease detection capability. In reality, this is not the case. High-end branded ECG machines generally deliver significantly better image clarity and disease detection rates than low-cost, lower-quality products. This difference primarily stems from superior signal processing technology. Big-brand ECG machines use chips that cost 20 times more than those in budget brands. This is the main reason they can display more detailed signals. This results in a substantial difference in image clarity and detail resolution.
Regarding fragmented waves (notching) in the aVR lead, these are only occasionally visible on big-brand ECG machines and are not displayed consistently. Budget ECG machines almost never show them. Our ECG system achieves a 99% display rate for fragmented waves in the aVR lead. This exceptional performance is made possible by our use of the worldâs only U.S.-patented ECG electrode, combined with multiple patented signal processing technologies.
Our patented electrodes offer excellent resistance to interference, baseline drift, and hair artifacts. Even when used with major-brand ECG machines, they can significantly improve the visibility of fragmented waves in the aVR lead. We not only utilize this patent but have also developed our own exclusive electrode gel formula, which further enhances signal acquisition and anti-interference performance.
In addition, our electrodes feature extremely strong adhesion, remaining securely attached even if the patient sweats heavily. They stay reliably in place during 24-hour Holter monitoring as well.
Key Features:
1) Strong anti-interference
2) Prevents baseline drift
3) Reduces hair artifacts
4) Super strong adhesion â stays in place even when patients sweat
PhysioSign USA
AMI with A-fib and CRBBB
What is the difference between the new ECG and the traditional ECG?
The biggest difference is in the image details. The details captured by the new ECG precisely represent the original disease foci. More importantly, they provide the natural recording of hidden, tricky, and clinically critical myocardial markers that are often needed.
Some experts ask: Why can traditional ECG only show CRBBB but cannot display the fragmented wave signals of myocardial damage?
First reason:
Traditional ECG is essentially a high-frequency convolution image. It is dominated by 99% ultra-high-frequency signals, so the tiny myocardial membrane potential signals are completely submerged by the high frequencies and cannot be recorded.
Second reason:
The QRS complex itself is not a sine wave but a pulse wave consisting of ultra-high and extremely high frequencies. Traditional ECG cannot display the extremely low-frequency injury potentials. When AMI or ACS occurs in the posterior wall or right wall, the right-sided conduction pathway is blocked, and it only manifests as a mimic CRBBB (Pseudo-CRBBB).
Doctors can apply ECG very precisely in clinical practice. The new ECG delivers results in 10 seconds, with both types of ECG images scanned synchronously. It performs AI-automated mapping of the full dataset (including invasive data), and an automated reading and interpretation system is available according to the doctorâs needs.
Figure 1:
Traditional ECG shows CRBBB only.
New ECG shows AMI with CRBBB.
Figure 2:
Traditional ECG shows AF with CRBBB.
New ECG shows AMI with AF and CRBBB.
PhysioSign USA
**CE MDR certified
**53 US & International patents
**Built on 15+ million recordings
CAD with Atrial Fibrillation & RBBB
Is ECG Useful? Undoubtedly, yes. No instrument can replace it. However, for more than 120 years, the images recorded by conventional ECG have remained unchanged. 99% of them are high-frequency convoluted waveforms.Â
Coronary Artery Disease (CAD) was discovered in 1973 and officially named by Harvard in 1976. Yet in clinical practice, doctors face enormous challenges. AMI/CAD/ACS accounts for more than 60% of cardiovascular diseases â even higher in some countries. Doctors frequently encounter cases where the ECG clearly shows a CRBBB pattern, but the final diagnosis is CAD, with coronary angiography (CAG) revealing stenosis or occlusion greater than 70%. The issue is not that the ECG image is poor, but that its resolution has been insufficient for over 120 years.
The new scientific discipline of âsignal processingâ â a key technology of the Third Industrial Revolution â only developed after the year 2000. Unfortunately, it has not been applied to traditional ECG image processing.
Traditional ECGs do capture all the signals through convolution, but unfortunately, the fine details are not displayed. It is similar to how X-ray and CT images of the same patient contain the same natural anatomical elements, yet reveal different diagnostic information depending on the modality. The same principle applies to traditional ECG versus new-generation ECG â the difference lies in the level of image detail.
Please refer to the attached Figure showing ECG images of 4 patients taken before their CAG results.
PhysioSign USA
*WPW with CAD*
In routine clinical practice, standard electrocardiograms (ECGs) identify common conduction and rhythm abnormalities such as premature beats, atrial fibrillation or flutter, bundle branch blocks, atrioventricular blocks, Wolff-Parkinson-White (WPW) syndrome, tachycardias, and bradycardias.
These patterns frequently represent secondary electrical phenomena.
Critically, they can obscure the underlying primary pathology: acute coronary syndromes, including ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and acute coronary syndrome (ACS)âencompassing myocardial infarction and unstable angina.
This diagnostic limitation stems from the technical focus of conventional ECG acquisition, which primarily captures high-frequency electrical signals. Since the 1970s, a period marked by the rising prevalence of coronary artery disease, clinicians have faced the persistent challenge that these prominent high-frequency patterns can mask the more subtle, often low-voltage, electrocardiographic signs of acute, evolving, or prior myocardial ischemia and infarction.
Example:Â A 52-year-old man undergoing two ECG synchronization tests prior to angiography. Coronary angiography (CAG) subsequently confirmed the findings, revealing a 95% blockage in the LCx and 65% stenosis with generalized plaque in the RCA.
[A] Existing ECG:Â Only demonstrates the WPW pattern (delta wave), with no clear signs of myocardial infarction or ischemia.
[B] new ECG: While this does not alter the standard (ECG) itself, it allows for the recording of detailed local electrical signals. In the atrial area (red circle), the technique clearly delineates the HV interval. A side-by-side comparison reveals that this specific signal is embedded within the Delta wave. This marks the first time in cardiac electrophysiology that the precise local signals folded into the Delta waveâand the reason for its appearanceâhave been clearly demonstrated. In the ventricular area (blue circle): Reveals epicardial injury currents and allows precise measurement of the ST segment duration (exact time length - ST segment 209.36ms) - ST segment < 120ms**considered the gold standard in textbooks.
[C] Back in the 1980s, experts already recognized that the duration of the ST segment (i.e., its time length along the X-axis) is important for diagnosing ischemia â rather than just ST-segment elevation or depression (Y-axis amplitude). Annotation: âS-T interval = ST segment + T wave, but traditional ECGs cannot measure it accurately.
PhysioSign USA
#Cardiology
#ECG
ST segment duration <120 ms (considered the gold standard in textbooks)
Since coronary artery disease (CAD) was first identified and named in 1976, it has become the most common cause of heart disease worldwide. However, many cases of CAD do not present with ST-segment elevation. Even after an acute myocardial infarction (AMI), approximately half of non-ST-elevation myocardial infarctions (NSTEMIs) persist without this feature, posing significant challenges for clinicians and highlighting the limitations of conventional ECG.
The new ECG technology scans the ST wavelet, enabling it to divide the S-T interval into two distinct segments and measure both the ST segment and T segment (providing precise timing data). This new ECG has undergone animal experiments and testing in MI models, revealing the great significance of this parameter. The combination of data and images allows it to record myocardial standards before a heart attack occurs. This pioneering invention represents one of the most important discoveries of the century and may prove to be the most clinically significant and valuable advancement in cardiac diagnostics.
**The most critical factor is the injury current inside the heart, which changes over time. Therefore, changes in duration (timing) typically occur in the early stage, while changes in amplitude are already a sign of more severe late-stage damage.** Thereâs no need for an entirely new ECG technologyâtraditional ECG can also detect certain changes. So, which is more important: the early changes or the late-stage sudden events? Of course, the early changes are far more important, because early intervention can prevent progression.
PhysioSign USA
EpCG was invented in 2017 with the aim of visualizing heart signals.
The recorded signal from the initial scan was processed using AI technology to isolate the full frequency spectrum of cardiac activity.
The total amplitude and duration of the P-QRS-T waves are consistent with those of conventional ECG.
The heart is a living organ that exhibits microelectronic properties. While ordinary cardiac muscle tissue performs mechanical work, specialized tissues play a crucial role in the excitation, pacing, and conduction functions of the heartbeat.
Many unresolved mysteries of the heart lie within the ultra-low frequency range, both above and below the axis. Atrial and ventricular repolarization represent the resting phase, when the heart appears to be in a state of dormancy.
The overall EpCG image aligns with the anatomical structure of the heart as observed post-dissection. The scientific foundation of EpCG elucidates the enigma of cardiac electrophysiological frequency distribution.
Traditional ECG images are represented as line waveforms, predominantly composed of high-frequency components.
For over a century, single-line waveforms have been used to diagnose diseases across different time frames.
EpCG's full-frequency cardiac images unveil numerous historical mysteries of the heart, demonstrating that conventional ECG primarily displays high-frequency electrical signals.
PhysioSign USA
Traditional ECG Interpretation in CRBBB:
When a complete right bundle branch block (CRBBB) is present, diagnosing an acute myocardial infarction (MI) is often challenging. This is because subtle, low-frequency ischemic changes are typically obscured by the high-amplitude, high-frequency signals associated with the conduction abnormality.
new ECG Interpretation:
A refined ECG analysis that reveals CRBBB with R-wave peak cracking (also described as notching or fragmentation of the R wave) provides an additional diagnostic clue. This specific finding indicates underlying ischemia or infarction and is particularly suggestive of left main coronary artery disease or a right posterior myocardial infarction.
***Observations in Lead aVR:
In lead aVR, injury currents can cause fragmentation of R-wave peaks, primarily associated with proximal lesions in the left main (LM) coronary artery, right coronary artery (RCA), or left anterior descending (LAD) artery.
A notched R-wave peak in lead aVR is a recognized marker of myocardial infarction (MI), though it remains undetectable on standard electrocardiograms (ECGs). Extensive research by international experts over the past century supports this finding. Unlike conventional ECGs, the innovative saahECG technology clearly visualizes this feature. Although notched R-waves are documented in medical literature, traditional ECG systems lack the resolution to capture them effectively.
PhysioSign USA
I would like to analyze the invention technology of our "Second Generation ECG". They are different.
ăaă saahECG is exactly the same as the traditional ECG in terms of high-frequency components, but it also incorporates ultra-low-frequency components, which are essentially the basic ion signal images. There was no change in the ECG itselfâjust more detailed images of the ionic signals. This is the first revolution since the existence of ECG. The traditional ECG is version 1.0, while the new ECG is version 2.0.
ăbă EpCG is completely different from the traditional ECG. It presents in three dimensions but is displayed in two dimensions. It has completely revolutionized the traditional ECG. It is a fully visual image, divided by frequency, dimension, and chronological layers. It will become the 3.0 version of ECG in the future. It will be particularly liked by surgeons who perform invasive procedures.
In terms of reading, analysis, identification, and judgment, the new ECG (saahECG) requires the foundation of traditional ECG (deep knowledge required).
PhysioSign USA